Congressional Stalemate Creates Chaos for Obamacare Shoppers
This year’s Obamacare open enrollment period, which started Nov. 1 in most states, is full…
Congressional Stalemate Creates Chaos for Obamacare Shoppers
This year’s Obamacare open enrollment period, which started Nov. 1 in most states, is full of uncertainty and confusion for the more than 24 million people who buy health insurance through the federal and state Affordable Care Act marketplaces. Even with sign-up season underway, the fate of the enhanced premium tax credits that make coverage…
Louisiana Took Months To Sound Alarm After Two Babies Died in Whooping Cough Outbreak
When there’s an outbreak of a vaccine-preventable disease, state health officials typically take certain steps to alert residents and issue public updates about the growing threat. That’s standard practice, public health and infectious disease experts told KFF Health News and NPR. The goal is to keep as many other vulnerable people as possible from getting…
The ‘After Phase’ Is Missing: Why Every GLP-1 Prescription Needs an Exit
By HOLLI BRADISH-LANE I’ve seen clients start GLP-1 medications full of hope—and stop them feeling betrayed by their own biology. Some reached their limit with side effects: relentless nausea, fatigue, or the quiet loss of joy in eating. Others simply couldn’t afford to stay on. A few never saw the promised results at all. But…
Change to UK Rare Disease Approval Process
The Times reports that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) is revising it’s approach to how it approves new medicines that treat rare diseases. How? Principally by allowing for single arm trials with real-world ‘digital twin’ controls as well as expediting the approval process. The new plan, which is being launched on…
3 Misconceptions Hospital Leaders Have About AI
During Reuters’ MedTech conference, medical device leaders shared three common misconceptions they believe hospital leaders often have about AI. They stressed that AI in healthcare is meant to augment — not replace — clinicians. The post 3 Misconceptions Hospital Leaders Have About AI appeared first on MedCity News.
4 Notable Health Tech Funding Announcements in October
Health tech companies made several major funding announcements in October. Here is a list of some of the biggest funding rounds. The post 4 Notable Health Tech Funding Announcements in October appeared first on MedCity News.
Qué ocurre cuando tus médicos ya no están en la red de tu aseguradora
El invierno pasado, Amber Wingler comenzó a recibir una serie de mensajes cada vez más urgentes del hospital local de Columbia, Missouri, informándole que la atención médica de su familia podría verse afectada pronto. MU Health Care, donde practican la mayoría de los médicos que utiliza su familia, estaba inmerso en una disputa contractual con…
Crothall Associates Pack Love into Suitcase Drive for Foster Children
Suzy Lohman felt compelled to act when she learned that foster children treated at Cincinnati Children’s Hospital Medical Center often lacked proper bags for their belongings. Inspired by a hospital newsletter request for suitcases, duffel bags, and backpacks, Suzy launched a drive among EVS employees to collect these essential items. Many foster children, she knew, relied…
How ACA Marketplace Costs Compare to Employer-Sponsored Health Insurance
This analysis compares ACA Marketplace costs to employer-sponsored health insurance costs and finds that individual market premiums have become more similar to employer-sponsored premiums since 2017. In 2024, individual market insurance premiums averaged $540 per member per month, slightly below the average $587 per member per month premium for fully-insured employer coverage.
Pfizer Lawsuits Allege Novo Nordisk’s Bid to Buy Obesity Biotech Metsera is Anticompetitive, Illegal
Pfizer claims Metsera breached their merger agreement, adding that a tie-up of the biotech with GLP-1 drug giant Novo Nordisk would violate U.S. antitrust law. Metsera called the arguments “nonsense” and said Pfizer is trying to buy the obesity drug developer for less than what Novo is willing to pay. The post Pfizer Lawsuits Allege…
